IL17F and Alzheimer disease: Regarding cytokines, higher levels of IL-17F were significantly associated with reduced odds of progression to both AD (OR = 0.726; 95% CI = 0.548–0.963; p = 0.026) and to ACLF (OR = 0.689; 95% CI = 0.477–0.995; p = 0.047).